Donor hepatocyte activity correlates with cell dose, donor hematopoietic engraftment, and time after transplantation
Cells injected . | No. animals . | Time after transplantation . | Human hepatocytes, % . | Human CD45+ cells, % . |
---|---|---|---|---|
BM 34+Lin- | 2 | 3 wk | 1.8 ± 0.05 | 0.8 |
3 ± 0.1 | 1.1 | |||
BM 34+Lin- | 2 | 5 wk | 2 ± 0.03 | 0.62 |
3.2 ± 0.01 | 1.5 | |||
BM 34+Lin- | 2 | 4 mo | 5.5 ± 0.2 | 0.87 |
10 ± 0.08 | 6.4 |
Cells injected . | No. animals . | Time after transplantation . | Human hepatocytes, % . | Human CD45+ cells, % . |
---|---|---|---|---|
BM 34+Lin- | 2 | 3 wk | 1.8 ± 0.05 | 0.8 |
3 ± 0.1 | 1.1 | |||
BM 34+Lin- | 2 | 5 wk | 2 ± 0.03 | 0.62 |
3.2 ± 0.01 | 1.5 | |||
BM 34+Lin- | 2 | 4 mo | 5.5 ± 0.2 | 0.87 |
10 ± 0.08 | 6.4 |
Values for human hepatocytes represent the average of hepatocytes found in 6 different liver sections from each of the animals analyzed at a given time point ± SD.
As it can be seen at each time point, a correlation exists between the percentage of human hepatocytes and the percentage of human CD45+ cells. Correlation coefficient was calculated according to the formula:
Levels of CD45+ cells of hematopoietic engraftment reflect only the levels of human CD45+ cells in PB and BM.